Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

The COSMOS trial found that a daily multivitamin delayed biological aging by 2.7 to 5.1 months, and that this effect was more apparent in older adults who are already experiencing accelerated aging.

Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today ...

Klothea Bio, Inc. (“Klothea Bio”), a clinical-stage biotechnology company developing therapeutics based on their proprietary serum klotho platform, today announced the launch of a randomized, ...

PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Tolerance Bio, a biopharmaceutical company pioneering innovative approaches to extending healthspan by preserving, restoring, and manipulating the function of ...

Scientific Longevity Company Collaborates with Major Academic Institutions to Remove Tumor Defense Mechanisms and Help Defeat Cancer in a Non-Toxic Manner MIAMI, Dec. 4, 2025 /PRNewswire/ -- Immorta ...

Researchers at the Buck Institute for Research on Aging have developed an epigenetic clock that could predict an individual’s intrinsic capacity score, a composite score that is a measure of healthy ...

News, 7 August 2025: Rejuve.Bio, the BioAI company pioneering a neural-symbolic AI‑driven co-scientist platform aimed at accelerating drug discovery for extending human healthspan and targeting ...

Company Adds Creative Leadership to Support Advancing Longevity Therapeutics Programs MIAMI, Feb. 18, 2026 /PRNewswire/ -- Immorta Bio Inc., a pioneering longevity biotechnology company dedicated to ...